Follow
Chandra Prakash Prasad
Chandra Prakash Prasad
Associate Professor, Department of Medical Oncology (Lab), AIIMS, New Delhi-29
Verified email at aiims.edu - Homepage
Title
Cited by
Cited by
Year
Potent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt/β-catenin signaling
CP Prasad, G Rath, S Mathur, D Bhatnagar, R Ralhan
Chemico-biological interactions 181 (2), 263-271, 2009
1722009
Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients
G Sharma, S Mirza, CP Prasad, A Srivastava, SD Gupta, R Ralhan
Life sciences 80 (20), 1873-1881, 2007
1482007
Expression analysis of E-cadherin, Slug and GSK3β in invasive ductal carcinoma of breast
CP Prasad, G Rath, S Mathur, D Bhatnagar, R Parshad, R Ralhan
BMC cancer 9 (1), 1-10, 2009
1462009
Promoter hypermethylation of TMS1, BRCA1, ERα and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients
S Mirza, G Sharma, CP Prasad, R Parshad, A Srivastava, SD Gupta, ...
Life sciences 81 (4), 280-287, 2007
1432007
Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/β-catenin pathway in invasive ductal carcinoma of breast
CP Prasad, S Mirza, G Sharma, R Prashad, S DattaGupta, G Rath, ...
Life sciences 83 (9-10), 318-325, 2008
1152008
Wnt signaling pathway in invasive ductal carcinoma of the breast: relationship between β-catenin, disheveled and cyclin D1 expression
CP Prasad, SD Gupta, G Rath, R Ralhan
Oncology 73 (1-2), 112-117, 2007
1042007
Environmental and occupational determinants of lung cancer
A Shankar, A Dubey, D Saini, M Singh, CP Prasad, S Roy, SJ Bharati, ...
Translational lung cancer research 8 (Suppl 1), S31, 2019
652019
Interleukin-6 drives melanoma cell motility through p38α-MAPK-dependent up-regulation of WNT5A expression
R Linnskog, G Jönsson, L Axelsson, CP Prasad, T Andersson
Molecular oncology 8 (8), 1365-1378, 2014
632014
Frequent loss of Dab2 protein and infrequent promoter hypermethylation in breast cancer
SAR Bagadi, CP Prasad, A Srivastava, R Prashad, SD Gupta, R Ralhan
Breast cancer research and treatment 104 (3), 277-286, 2007
602007
WNT-5A triggers Cdc42 activation leading to an ERK1/2 dependent decrease in MMP9 activity and invasive migration of breast cancer cells
CP Prasad, SK Chaurasiya, L Axelsson, T Andersson
Molecular oncology 7 (5), 870-883, 2013
572013
Non-canonical WNT5A signaling up-regulates the expression of the tumor suppressor 15-PGDH and induces differentiation of colon cancer cells
LM Mehdawi, CP Prasad, R Ehrnström, T Andersson, A Sjölander
Molecular oncology 10 (9), 1415-1429, 2016
552016
Feasibility of lung cancer screening in developing countries: challenges, opportunities and way forward
A Shankar, D Saini, A Dubey, S Roy, SJ Bharati, N Singh, M Khanna, ...
Translational lung cancer research 8 (Suppl 1), S106, 2019
522019
Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model
G Canesin, S Evans-Axelsson, R Hellsten, A Krzyzanowska, CP Prasad, ...
PLoS One 12 (9), e0184418, 2017
512017
WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition
CP Prasad, SK Chaurasiya, W Guilmain, T Andersson
Journal of Experimental & Clinical Cancer Research 35 (1), 1-15, 2016
412016
Clinical significance of promoter hypermethylation of RASSF1A, RARβ2, BRCA1 and HOXA5 in breast cancers of Indian patients
SAR Bagadi, CP Prasad, J Kaur, A Srivastava, R Prashad, SD Gupta, ...
Life sciences 82 (25-26), 1288-1292, 2008
412008
WNT5A as a therapeutic target in breast cancer
CP Prasad, M Manchanda, P Mohapatra, T Andersson
Cancer and Metastasis Reviews 37 (4), 767-778, 2018
382018
Role of complementary and alternative medicine in prevention and treatment of COVID-19: an overhyped hope
A Shankar, A Dubey, D Saini, CP Prasad
Chinese journal of integrative medicine 26 (8), 565, 2020
342020
Cancer research in India: Challenges & opportunities
M Singh, CP Prasad, TD Singh, L Kumar
The Indian journal of medical research 148 (4), 362, 2018
322018
Expression analysis of maspin in invasive ductal carcinoma of breast and modulation of its expression by curcumin in breast cancer cell lines
CP Prasad, G Rath, S Mathur, D Bhatnagar, R Ralhan
Chemico-biological interactions 183 (3), 455-461, 2010
322010
Therapy for BRAFI-resistant melanomas: Is WNT5A the answer?
CP Prasad, P Mohapatra, T Andersson
Cancers 7 (3), 1900-1924, 2015
302015
The system can't perform the operation now. Try again later.
Articles 1–20